News | January 26, 2022
Cipla’s Q3FY22 PAT at Rs 729 cr.
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Biogen paid Ionis a US $ 60 million one-time upfront payment
The Home Healthcare market is expected to be US $ 14.2 by 2025
Vakrangee through its Nextgen Kendras and BharatEasy Mobile Superaap will now be able to provide medicines & healthcare services in remote areas of the country
During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests
Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
Cipla has reported consolidated financial results for the period ended September 30, 2021
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
It is the first presbyopia-correcting lens implant for cataract surgery
Subscribe To Our Newsletter & Stay Updated
